Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Emisphere Technologies, Inc.
EMIS
Healthcare
Drug Manufacturers - Major
"Emisphere Technologies Inc is a pharmaceutical and drug delivery company. It aims to partner its proprietary drug delivery technology and license its first medical food product Eligen B12, which is used to normalize vitamin B12 levels without an injection. The company is in partnership with global pharmaceutical companies to develop new oral formulations of existing injectable bio...
-pharmaceutical products, as well as new chemical entities, using its Eligen Technology. The company recognizes its
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (OTCPK:EMIS)
New Post
View:
Posts & Comments
Threaded Posts
(0)
•••
queue
X
View Profile
View Bullboard History
Comment by
queue
on May 17, 2002 6:17pm
RE: new low $5.25
company cash $119 mm shares/out 17.8 mm cash/sh $6.68
(0)
•••
queue
X
View Profile
View Bullboard History
Comment by
queue
on May 15, 2002 3:45pm
new lows
https://cbs.marketwatch.com/tools/quotes/basic.asp?symb=EMIS&sid=5847&siteid=mktw&dist=mat
(0)
•••
SCCNewsServices
X
View Profile
View Bullboard History
Comment by
SCCNewsServices
on Apr 19, 2000 5:34pm
Proper link for story below
https://www.smallcapcenter.com/story.asp?&mb=1storytype=sccnews&component=story.asp&storyid=6726
(0)
•••
SCCNewsServices
X
View Profile
View Bullboard History
Comment by
SCCNewsServices
on Apr 19, 2000 5:31pm
Stock rises after
Drug delivery specialist Emisphere Technologies Inc.?s (NASDAQ: EMIS) stock rose as much as 20% after the company said human trials showed that its capsule version of a widely-used anti-clotting drug
...more
(0)
•••
mhogan
X
View Profile
View Bullboard History
Comment by
mhogan
on Jan 30, 2000 6:50pm
FYI
In the news, EMIS received a nice little blurb on January 20th in the Hambrecht and Quist 18th Annual Healthcare Conference Issue regarding the continuing success and broadening use of its Herapin
...more
(0)
•••
baum
X
View Profile
View Bullboard History
Comment by
baum
on Jun 28, 1999 3:51pm
emis
I believe this stock will be worth more than 100 in 2 years. Does any reason why oral heparin won't be that big?
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
This Small-Cap Gold Stock Jumped Almost 50% on Friday
Nanalysis Scientific Corp. Announces First Quarter 2024 Results